Nivolumab 360 / Carboplatin 5 / Paclitaxel 175, Non-Small Cell Lung Cancer, neoadjuvant, cycle 1-4 (PID2642 V1.0)
Carboplatin (ATC L01XA02)
- PC Compound: Carboplatin
- PC Substance: Carboplatin
Cimetidine (ATC A02BA01)
- PC Compound: Cimetidine
Dexamethasone (ATC H02AB02)
- PC Compound: Dexamethasone
- PC Substance: Dexamethason
Dimetinden (ATC R06AB03)
- PC Compound: Dimetinden
- PC Substance: Dimetinden
- PC Substance: Dimetindenmaleat
Fosaprepitant (ATC A04AD12)
- EMA EPAR: Fosaprepitant (ivemend)
- PC Compound: Fosaprepitant
- PC Substance: Fosaprepitant
Granisetron (ATC A04AA02)
- EMA EPAR: Granisetron (Sancuso, 3.1 mg/24 hours transdermal
- EMA URL: Kytril, granisetron
- PC Compound: Granisetron
- PC Substance: Granisetron
Nivolumab (ATC L01FF01)
- EMA EPAR: Nivolumab (Opdivo)
- FDA: Nivolumab (Opdivo)
- PC Substance: Nivolumab
- PC Substance: Nivolumab
Paclitaxel (ATC L01CD01)
- EMA EPAR: Paclitaxel (Pazenir)
- PC Compound: Nab-paclitaxel
- PC Substance: Paclitaxel
- PMID: One-hour paclitaxel infusions: review of safety and efficacy.
- PMID: Paclitaxel (Taxol): phase I/II trial comparing 1-hour infusion schedules.